Fingerprint Dive into the research topics of 'CD30 targeting with brentuximab vedotin: A novel therapeutic approach to primary effusion lymphoma'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
CD30 targeting with brentuximab vedotin: A novel therapeutic approach to primary effusion lymphoma
Shruti Bhatt, Brittany M. Ashlock, Yasodha Natkunam, Victoria Sujoy, Jennifer Rose Chapman, Juan Carlos Ramos, Enrique A. Mesri, Izidore S. Lossos
Research output: Contribution to journal › Article › peer-review
55
Scopus
citations